Mineralys Therapeutics (MLYS) Interest & Investment Income (2022 - 2026)
Quarterly results put Interest & Investment Income at $6.0 million for Q1 2026, up 167.8% from a year ago — trailing twelve months through Mar 2026 was $19.7 million (up 51.92% YoY), and the annual figure for FY2025 was $16.0 million, up 9.36%.
Mineralys Therapeutics has reported Interest & Investment Income over the past 5 years, most recently at $6.0 million for Q1 2026.
- Interest & Investment Income reached $6.0 million in Q1 2026 per MLYS's latest filing, down from $6.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $6.0 million in Q4 2025 and bottomed at $741000.0 in Q3 2022.
- Median Interest & Investment Income over the past 5 years was $3.5 million (2023), compared with a mean of $3.4 million.
- The largest annual shift saw Interest & Investment Income skyrocketed 374.09% in 2023 before it crashed 41.89% in 2025.
- Over 5 years, Interest & Investment Income stood at $935000.0 in 2022, then soared by 255.19% to $3.3 million in 2023, then fell by 15.42% to $2.8 million in 2024, then surged by 115.2% to $6.0 million in 2025, then dropped by 0.81% to $6.0 million in 2026.
- Business Quant data shows Interest & Investment Income for MLYS at $6.0 million in Q1 2026, $6.0 million in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 4.20 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 3.59 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 935,000.00 |
| Sep 30, 2022 | 741,000.00 |